JHS SVENDGAARD LABORATORIES
|
JHS SVENDGAARD LABORATORIES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -0.35 | -2.20 | -0.62 | 0.19 | -0.33 |
| CEPS(Rs) | 0.29 | -1.47 | 0.43 | 1.33 | 0.64 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 21.67 | 22.16 | 28.60 | 27.56 | 29.16 |
| Tax Rate(%) | -18.35 | 23.66 | 4,264.47 | -38.71 | 16.91 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | -1.32 | -10.70 | -0.98 | 1.90 | 1.19 |
| EBIT Margin(%) | -4.19 | -26.41 | 1.74 | 2.19 | -2.78 |
| Pre Tax Margin(%) | -4.84 | -27.05 | 0.12 | 0.96 | -4.17 |
| PAT Margin (%) | -5.73 | -20.65 | -4.97 | 1.33 | -3.47 |
| Cash Profit Margin (%) | 3.23 | -13.56 | 3.20 | 8.52 | 2.79 |
| Performance Ratios | |||||
| ROA(%) | -2.01 | -8.11 | -1.98 | 0.60 | -2.17 |
| ROE(%) | -2.36 | -9.75 | -2.36 | 0.76 | -2.74 |
| ROCE(%) | -1.71 | -12.43 | 0.82 | 1.24 | -2.15 |
| Asset Turnover(x) | 0.35 | 0.39 | 0.40 | 0.45 | 0.63 |
| Sales/Fixed Asset(x) | 0.60 | 0.88 | 0.96 | 1.16 | 1.59 |
| Working Capital/Sales(x) | 3.48 | 1.76 | 1.44 | 1.03 | 1.71 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.66 | 1.14 | 1.04 | 0.87 | 0.63 |
| Receivable days | 80.98 | 78.87 | 162.56 | 280.04 | 195.53 |
| Inventory Days | 66.11 | 54.01 | 50.23 | 31.19 | 19.07 |
| Payable days | 237.90 | 166.85 | 139.67 | 208.84 | 145.67 |
| Valuation Parameters | |||||
| PER(x) | - | - | - | 107.20 | - |
| PCE(x) | 56.16 | -10.71 | 48.27 | 14.94 | 11.66 |
| Price/Book(x) | 0.76 | 0.71 | 0.72 | 0.72 | 0.26 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.72 | 1.00 | 1.48 | 1.07 | 0.33 |
| EV/Core EBITDA(x) | 36.03 | 37.75 | 14.93 | 11.43 | 2.93 |
| EV/EBIT(x) | -41.00 | -3.79 | 85.26 | 49.00 | -11.69 |
| EV/CE(x) | 0.70 | 0.49 | 0.68 | 0.61 | 0.25 |
| M Cap / Sales | 1.81 | 1.45 | 1.55 | 1.28 | 0.33 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -16.53 | -1.67 | -14.40 | -27.57 | 12.09 |
| Core EBITDA Growth(%) | 50.21 | -73.70 | -9.66 | -38.98 | 155.20 |
| EBIT Growth(%) | 86.75 | -1,596.63 | -32.21 | 156.75 | -284.70 |
| PAT Growth(%) | 76.84 | -308.38 | -419.53 | 127.65 | -191.19 |
| EPS Growth(%) | 84.11 | -253.05 | -435.46 | 157.26 | -190.70 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.02 | - | - | - | - |
| Current Ratio(x) | 1.87 | 2.31 | 4.18 | 5.23 | 2.69 |
| Quick Ratio(x) | 1.33 | 1.96 | 3.54 | 4.73 | 2.61 |
| Interest Cover(x) | -6.44 | -40.98 | 1.07 | 1.78 | -1.99 |
| Total Debt/Mcap(x) | 0.03 | - | 0.01 | 0.01 | 0.02 |
Compare Financial Ratios of peers of JHS SVENDGAARD LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JHS SVENDGAARD LABORATORIES | ₹119.4 Cr | 0.5% | 3% | -20.9% | Stock Analytics | |
| HINDUSTAN UNILEVER | ₹548,383.0 Cr | -0.6% | 4% | 4.4% | Stock Analytics | |
| GODREJ CONSUMER PRODUCTS | ₹126,976.0 Cr | -1.7% | 7.3% | -0.9% | Stock Analytics | |
| DABUR INDIA | ₹82,031.8 Cr | -3.9% | 0.2% | -11.6% | Stock Analytics | |
| COLGATEPALMOLIVE (INDIA) | ₹69,387.6 Cr | -2.5% | 5.3% | -10.9% | Stock Analytics | |
| PROCTER & GAMBLE HYGIENE AND HEALTH CARE | ₹45,237.6 Cr | -1.8% | 0% | -11.7% | Stock Analytics | |
JHS SVENDGAARD LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JHS SVENDGAARD LABORATORIES | 0.5% |
3% |
-20.9% |
| SENSEX | -1.3% |
4.1% |
7.6% |
You may also like the below Video Courses
